Skip to main content
. 2013 Oct 2;33(40):15815–15826. doi: 10.1523/JNEUROSCI.1790-13.2013

Figure 6.

Figure 6.

A–C, Mean time series of the percentage change in gamma power (60–90 Hz) aligned to the onset of the warning cue (A), the imperative cue (B), and movement onset (C) for the four different reward and trial-complexity conditions. Movement-related gamma power synchronization is greater on medication than off medication. Movement-related gamma power increases are augmented in high-complexity trials (C).